SWA
ORGO icon

Sutton Wealth Advisors’s Organogenesis Holdings ORGO Stock Holding History

Sutton Wealth Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,885
Closed -$10.5K – 1332
2022
Q4 		$10.5K Buy
3,885
+1,337
+52% +$3.9K ﹤0.01% 929
2022
Q3 		$8.26K Buy
2,548
+2,522
+9,700% +$11.4K ﹤0.01% 954
2022
Q2 		$127 Sell
26
-1,343
-98% -$8.27K ﹤0.01% 1599
2022
Q1 		$10.4K Buy
1,369
+461
+51% +$3.57K ﹤0.01% 921
2021
Q4 		$8.39K Buy
908
+341
+60% +$3.62K ﹤0.01% 984
2021
Q3 		$8.07K Buy
567
+29
+5% +$450 ﹤0.01% 979
2021
Q2 		$8.94K Buy
+538
New +$10K ﹤0.01% 941

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Sutton Wealth Advisors's ORGO Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of Organogenesis Holdings (ORGO) in Q1 2023, closing a stake of 3,885 shares — an estimated $10.5K sold.

Sutton Wealth Advisors first reported a position in ORGO in Q2 2021 and held it in 7 quarters. The position peaked at $10.5K in Q4 2022. 131 funds tracked by Wall St. Rank hold ORGO as of Q1 2023.

  • Sutton Wealth Advisors reported no remaining Organogenesis Holdings position as of Q1 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 3,885 Organogenesis Holdings shares in Q1 2023, an estimated $10.5K.
  • Sutton Wealth Advisors first reported a position in Organogenesis Holdings in Q2 2021 and held it in 7 quarters.
  • Sutton Wealth Advisors's Organogenesis Holdings position peaked at $10.5K in Q4 2022.
  • 131 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.